KB
MDT icon

Kimelman & Baird’s Medtronic MDT Stock Holding History

Kimelman & Baird’s Portfolio MDT Stock Details MDT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$14.7M Buy
169,890
+500
+0.3% +$47.9K 1.21% 29
2025
Q4 		$16.3M Buy
169,390
+421
+0.2% +$40.9K 1.25% 28
2025
Q3 		$16.1M Buy
168,969
+29,978
+22% +$2.76M 1.26% 26
2025
Q2 		$12.1M Buy
138,991
+132,790
+2,141% +$11.3M 0.99% 30
2025
Q1 		$557K Buy
6,201
+6,010
+3,147% +$538K 0.05% 87
2024
Q4 		$15.3K Hold
191
– – ﹤0.01% 248
2024
Q3 		$17.2K Hold
191
– – ﹤0.01% 243
2024
Q2 		$15K Buy
+191
New +$15.7K ﹤0.01% 252

Other funds holding MDT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Kimelman & Baird's MDT Position: Q1 2026 in Review

Kimelman & Baird increased its Medtronic (MDT) stake by 0.3% in Q1 2026, buying an estimated $47.9K and bringing the position to 169,890 shares worth $14.7M. The position accounts for 1.21% of the portfolio, ranked #29.

Kimelman & Baird first reported a position in MDT in Q2 2024 and has held it in 8 quarters since. The position peaked at $16.3M in Q4 2025. 2,229 funds tracked by Wall St. Rank hold MDT as of Q1 2026.

  • Kimelman & Baird held 169,890 shares of Medtronic worth $14.7M as of Q1 2026.
  • Kimelman & Baird bought 500 Medtronic shares in Q1 2026, an estimated $47.9K.
  • Medtronic made up 1.21% of Kimelman & Baird's portfolio in Q1 2026, its #29 holding.
  • Kimelman & Baird first reported a position in Medtronic in Q2 2024 and has held it in 8 quarters since.
  • Kimelman & Baird's Medtronic position peaked at $16.3M in Q4 2025.
  • 2,229 funds tracked by Wall St. Rank held Medtronic as of Q1 2026.

Based on Kimelman & Baird's 13F filing for Q1 2026, filed 13 May 2026.